Sarah J George Selected Research

Sarah J George Research Topics

Disease

16	Atherosclerotic Plaque (Atheroma) 01/2022 - 10/2005
14	Atherosclerosis 01/2022 - 07/2004
7	Rupture 01/2017 - 10/2005
5	Neointima 06/2017 - 06/2003
4	Aneurysm (Aneurysms) 09/2021 - 01/2017
3	Inflammation (Inflammations) 10/2017 - 04/2011
3	Infections 06/2017 - 05/2006
2	Stroke (Strokes) 01/2022 - 06/2010
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 03/2016
2	Vascular Diseases (Vascular Disease) 09/2007 - 07/2004
2	Neoplasms (Cancer) 07/2004 - 06/2002
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2004 - 06/2002
1	Coronary Disease (Coronary Heart Disease) 05/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Retinoblastoma (Glioblastoma, Retinal) 01/2022
1	Vascular Remodeling 01/2019
1	Congenital Heart Defects (Congenital Heart Defect) 01/2018
1	Right Ventricular Hypertrophy 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Pulmonary Hypertension 01/2018
1	Hyperplasia 10/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Abdominal Aortic Aneurysm 01/2017
1	Myocardial Infarction 09/2011
1	Necrosis 04/2011
1	Hypoxia (Hypoxemia) 04/2011
1	Acute Kidney Injury (Acute Renal Failure) 04/2011
1	Carotid Artery Injuries 02/2011
1	Melanoma (Melanoma, Malignant) 06/2002
1	Carcinogenesis 06/2002

Drug/Important Bio-Agent (IBA)

7	ApolipoproteinsIBA 09/2021 - 05/2006
6	Cadherins (E-Cadherin)IBA 12/2017 - 02/2009
6	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 10/2005
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2009
4	Apolipoproteins E (ApoE)IBA 09/2021 - 05/2006
4	Tissue Inhibitor of Metalloproteinase-3IBA 01/2017 - 06/2002
3	Cyclin D1IBA 01/2022 - 07/2004
3	Metalloproteases (Metalloproteinases)IBA 01/2017 - 06/2009
3	Tissue Inhibitor of Metalloproteinase-1IBA 02/2016 - 06/2003
3	Tissue Inhibitor of MetalloproteinasesIBA 02/2016 - 06/2002
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2022 - 01/2022
2	Angiotensin IIIBA 09/2021 - 01/2017
2	CollagenIBA 01/2017 - 06/2009
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 04/2011
2	Tissue Inhibitor of Metalloproteinase-2IBA 02/2016 - 05/2006
2	beta CateninIBA 09/2007 - 07/2004
1	Biological ProductsIBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	Pharmaceutical PreparationsIBA 09/2021
1	Galectin 3 (LGALS3)IBA 01/2020
1	Long Noncoding RNAIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Wnt-5a ProteinIBA 01/2019
1	Contractile ProteinsIBA 01/2018
1	CateninsIBA 06/2017
1	locked nucleic acidIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	ElastinIBA 01/2017
1	MetalsIBA 03/2016
1	Phenobarbital (Luminal)FDA Link 09/2011
1	Endothelins (Endothelin)IBA 04/2011
1	SodiumIBA 04/2011
1	Vasoconstrictor AgentsIBA 04/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2011
1	Endothelin-1 (Endothelin 1)IBA 04/2011
1	Interleukin-18 (Interleukin 18)IBA 04/2011
1	Endothelin A ReceptorIBA 04/2011
1	salicylhydroxamic acid (SHAM)IBA 04/2011
1	Adenosine Triphosphate (ATP)IBA 04/2011
1	Adenosine (Adenocard)FDA LinkGeneric 04/2011
1	sitaxsentanIBA 04/2011
1	Peptides (Polypeptides)IBA 03/2011
1	Wnt4 ProteinIBA 02/2011
1	RNA (Ribonucleic Acid)IBA 02/2011
1	LipidsIBA 06/2009
1	Cytochalasin DIBA 02/2007
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2007
1	Sirolimus (Rapamycin)FDA Link 02/2007
1	Matrix Metalloproteinase InhibitorsIBA 08/2006
1	RS-130830IBA 08/2006
1	EnzymesIBA 08/2006
1	Catalytic RNA (Ribozymes)IBA 07/2004
1	Matrix Metalloproteinase 13IBA 07/2004
1	R-cadherinIBA 07/2004
1	Collagen Type IV (Type IV Collagen)IBA 06/2003

Therapy/Procedure

3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 05/2022 - 10/2017
3	Therapeutics 12/2020 - 06/2002
2	Ligation 01/2022 - 09/2011
2	Stents 03/2016 - 07/2004
1	Length of Stay 01/2022
1	Carotid Endarterectomy 01/2019
1	Drug Therapy (Chemotherapy) 01/2017
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 04/2011
1	Injections 06/2002